YuHui Wang - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

YuHui Wang

Showing results (631-640 of 634) with videos related to

Pageof 64

Sort By:

You have reached the last page of results.This site can display upto 634 results.

Nature Communications|March 12, 2025

SR-A3 suppresses AKT activation to protect against MAFLD by inhibiting XIAP-mediated PTEN degradationPingping Lai, Guolin Miao, Yinqi Zhao, et al.

Plos Biology|May 7, 2021

Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopesDan Fu, Guangshun Zhang, Yuhui Wang, et al.

Nature Chemical Biology|February 26, 2020

A drug discovery platform to identify compounds that inhibit EGFR triple mutantsPunit Saraon, Jamie Snider, Yannis Kalaidzidis, et al.

Nature Communications|May 12, 2021

A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomesYu Guo, Lisu Huang, Guangshun Zhang, et al.

Pageof 64

Search research articles

Showing results (631-640 of 634) with videos related to

Sort By:

Pageof 64

You have reached the last page of results.This site can display upto 634 results.

Nature Communications|March 12, 2025

SR-A3 suppresses AKT activation to protect against MAFLD by inhibiting XIAP-mediated PTEN degradationPingping Lai, Guolin Miao, Yinqi Zhao, et al.

Plos Biology|May 7, 2021

Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopesDan Fu, Guangshun Zhang, Yuhui Wang, et al.

Nature Chemical Biology|February 26, 2020

A drug discovery platform to identify compounds that inhibit EGFR triple mutantsPunit Saraon, Jamie Snider, Yannis Kalaidzidis, et al.

Nature Communications|May 12, 2021

A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomesYu Guo, Lisu Huang, Guangshun Zhang, et al.

Pageof 64